miR-31 as a prognostic and predictive marker of disease-free survival (DFS) in resected stage III colon cancer: A retrospective analysis of the PETACC-8 trial.
暂无分享,去创建一个
P. Laurent-Puig | C. Lepage | S. Martin-Lannerée | J. Taieb | C. Mulot | Y. Gaston Mathe | C. Vazart | K. Fontaine | A. Caumont | F. Montestruc | K. Le Malicot